AskGene Pharma
Organization
Trials
Phase 3, Active, not recruiting, 780 people, Jan 16, 2024
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Phase 1/2, Recruiting, 594 people, May 22, 2023
Phase 1/2, Active, not recruiting, 62 people, Dec 1, 2022
Sources: clinicaltrials.gov